EV/EBITDA:
-16.88+0.31(+1.80%)Summary
- As of today (September 16, 2025), APLS EV/EBITDA is -16.88, with a rise of +0.31 (+1.80%) during the most recent trading session on September 15, 2025.
- Over the past year, APLS EV/EBITDA has dropped by -1.80 (-11.94%).
- APLS EV/EBITDA is now -343.04% below its all-time high of -3.81.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.8% | -1.8% | -1.9% |
| 1 m1 month | +11.8% | -11.8% | -12.1% |
| 3 m3 months | -25.7% | +28.4% | +29.5% |
| 6 m6 months | +12.6% | +0.8% | -1.1% |
| ytdytd | +31.7% | -21.1% | -23.6% |
| 1 y1 year | -11.9% | -32.3% | -35.2% |
| 5 y5 years | -248.8% | +68.4% | -21.8% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -16.88 | at high | -19.74 | +14.5% |
| 3 m | 3-month | -12.12 | -39.3% | -19.74 | +14.5% |
| 6 m | 6-month | -11.74 | -43.8% | -19.74 | +14.5% |
| 1 y | 1-year | -11.74 | -43.8% | -26.77 | +36.9% |
| 3 y | 3-year | -4.27 | -295.3% | -26.77 | +36.9% |
| 5 y | 5-year | -4.27 | -295.3% | -26.77 | +36.9% |
| alltime | all time | -3.81 | -343.0% | -30.85 | +45.3% |
APLS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.88(-31.7%) |
| 2024 | -24.70(+84.1%) |
| 2023 | -13.42(+50.6%) |
| 2022 | -8.91(+15.7%) |
| Date | Value |
|---|---|
| 2021 | -7.70(-57.5%) |
| 2020 | -18.10(+195.3%) |
| 2019 | -6.13(-2.5%) |
| 2018 | -6.29 |
FAQ
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of APLS is -16.88
What is the all time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high EV/EBITDA is -3.81
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals, Inc. EV/EBITDA has changed by +7.82 (+31.66%) since the beginning of the year
What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -1.80 (-11.94%)